PharmaLinx LLC – Trademark Portfolio

Entity Type: 16

PharmaLinx LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 4 filings in this category. The portfolio also extends into Class 16 (Paper Goods) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include READ. THINK. PARTICIPATE.. The owner is based in Titusville, NJ.

244 Jacobs Creek Road

Titusville, NJ 085601403

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

PharmaLinx LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (4 filings)

Education; providing of training; entertainment; sporting and cultural activities

16
Paper Goods (3 filings)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does PharmaLinx LLC have?

PharmaLinx LLC has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned, 2 cancelled.

What trademark classes does PharmaLinx LLC file in?

PharmaLinx LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 16 (Paper Goods), Class 35 (Advertising & Business). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What are PharmaLinx LLC's most well-known trademarks?

PharmaLinx LLC's registered trademark portfolio includes well-known marks such as READ. THINK. PARTICIPATE.. These are among 1 currently registered trademark in the portfolio.

What is PharmaLinx LLC's trademark registration success rate?

PharmaLinx LLC has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.